Stocking the Perfect Lab: Dare to Dream

Photos courtesy of Sandia National Laboratories, Center for Integrated Nanotechnologies Everyone knows that all labs are not created equally. What differentiates the Cold Spring Harbors and Max Plancks of the world from less-illustrious facilities? Certainly money plays a part, but so, too, does some intangible quality--call it critical mass, if you like--a fusion of the right people, resources, architecture, and vision that combine and cooperate to make a whole that is greater by far than th

Written byKelli Miller
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Everyone knows that all labs are not created equally. What differentiates the Cold Spring Harbors and Max Plancks of the world from less-illustrious facilities? Certainly money plays a part, but so, too, does some intangible quality--call it critical mass, if you like--a fusion of the right people, resources, architecture, and vision that combine and cooperate to make a whole that is greater by far than the sum of its parts.

Across the country, technology initiatives and consortia are rising up to tackle the new sciences--the 'omics, systems biology, and the like. As construction begins on new, state-of-the-art laboratories, it seems appropriate to pause and ask, just what does it take to build a dream lab?

Researchers in genomics, proteomics, structural biology, nanotechnology, and pharmacology were asked to envision their ideal research environments. Their answers reveal common themes--personnel and computing power, for instance--as well as field-specific requests.

Some long for top-notch ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies